Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Angina
Auxilius Pharma Announces Successful Conclusion of First-in-Human Clinical Trial of AUX-001 for Treatment of Chronic Stable Angina Pectoris
03/15/2024

Auxilius Pharma News

Auxilius Pharma News
The study's topline results showed that AUX-001 effectively extended the half-life of nicorandil from the standard 49±8 min, as seen with the current immediate-release form administered twice daily, to over 9 hours.
The study's topline results showed that AUX-001 effectively extended the half-life of nicorandil from the standard 49±8 min, as seen with the current immediate-release form administered twice daily, to over 9 hours.
The study's topline results...
03/15/2024
Cath Lab Digest

Advertisement

Conformal Medical's CLAAS® Implant
Left Atrial Appendage Occlusion
CRT 2024: Conformal Medical's CLAAS System Demonstrates Low Thrombogenicity Compared to Commercially Available LAAO Devices
03/13/2024

Conformal Medical News

Conformal Medical News
An in vitro study compared the relative thrombogenicity of the CLAAS implant to the Watchman FLX device. When compared to the Watchman FLX, the CLASS device demonstrated incomplete coverage with seemingly thinner thrombus and 44% lower...
An in vitro study compared the relative thrombogenicity of the CLAAS implant to the Watchman FLX device. When compared to the Watchman FLX, the CLASS device demonstrated incomplete coverage with seemingly thinner thrombus and 44% lower...
An in vitro study compared the...
03/13/2024
Cath Lab Digest
Critical Limb Ischemia
Researchers Develop Stem Cell Therapy to Prevent Amputations From Critical Limb Ischemia
03/13/2024

National Research Council of Science and Technology News

National Research Council of Science ...
A research team led by Dr. Sangheon Kim of the Center for Biomaterials Research at the Korea Institute of Science and Technology (KIST) announced that they have developed a three-dimensional stem cell therapy to treat critical limb ischemia...
A research team led by Dr. Sangheon Kim of the Center for Biomaterials Research at the Korea Institute of Science and Technology (KIST) announced that they have developed a three-dimensional stem cell therapy to treat critical limb ischemia...
A research team led by Dr....
03/13/2024
Cath Lab Digest
Embolic Protection
Emboline Announces That First 100 Patients Have Been Treated in IDE Study of Emboliner Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
03/13/2024

Emboline, Inc. News

Emboline, Inc. News
The Emboliner is the first device to provide full brain and body protection from ischemic events such as stroke caused by embolic debris released into the bloodstream during transcatheter heart procedures.
The Emboliner is the first device to provide full brain and body protection from ischemic events such as stroke caused by embolic debris released into the bloodstream during transcatheter heart procedures.
The Emboliner is the first...
03/13/2024
Cath Lab Digest

Advertisement

BioCardia
Stem Cell Therapy
BioCardia and StemCardia Announce Partnership to Deliver Cell-Gene Therapy for Remuscularization of Heart
03/13/2024

BioCardia and StemCardia News

BioCardia and StemCardia News
Under the partnership, BioCardia is the exclusive biotherapeutic delivery partner for StemCardia’s cell therapy candidate through studies expected to result in FDA approval of an investigational new drug application (IND) and the anticipated...
Under the partnership, BioCardia is the exclusive biotherapeutic delivery partner for StemCardia’s cell therapy candidate through studies expected to result in FDA approval of an investigational new drug application (IND) and the anticipated...
Under the partnership, BioCardia...
03/13/2024
Cath Lab Digest
Depression and CV Risk
Women With Depression Face Higher Cardiovascular Risk Than Men
03/12/2024

American College of Cardiology News

American College of Cardiology News ...
One explanation is that women may experience more severe and persistent symptoms of depression compared to men, and they may be more likely to have depression during critical periods of hormonal changes, such as pregnancy or menopause.  
One explanation is that women may experience more severe and persistent symptoms of depression compared to men, and they may be more likely to have depression during critical periods of hormonal changes, such as pregnancy or menopause.  
One explanation is that women...
03/12/2024
Cath Lab Digest
Risk Scores
Novel Risk Score Developed to Evaluate Risk of Cardiovascular Complications After Bone Marrow Transplant
03/12/2024

Michigan Medicine - University of Michigan News

Michigan Medicine - University of Mic...
The most common short and long term condition was atrial fibrillation, with 6.8% of patients diagnosed at the five-year mark, followed by 5.4% of patients experiencing heart failure.
The most common short and long term condition was atrial fibrillation, with 6.8% of patients diagnosed at the five-year mark, followed by 5.4% of patients experiencing heart failure.
The most common short and long...
03/12/2024
Cath Lab Digest

Advertisement

TAVR
CRT 2024: New Late-Breaking Data From Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-Effectiveness Benefits of TAVR Platform
03/11/2024

Medtronic News

Medtronic News
Evolut Low Risk Trial four-year data were analyzed to determine cost-effectiveness results of TAVR versus SAVR across the spectrum of surgical mortality risk. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients...
Evolut Low Risk Trial four-year data were analyzed to determine cost-effectiveness results of TAVR versus SAVR across the spectrum of surgical mortality risk. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients...
Evolut Low Risk Trial four-year...
03/11/2024
Cath Lab Digest
Drug-Coated Balloons
CRT 2024: BIDMC-Led Trial Leads to FDA Approval of Coronary Drug-Coated Balloons
03/11/2024

Beth Israel Deaconess Medical Center News

Beth Israel Deaconess Medical Center ...
Researchers reported that patients treated with a balloon coated with paclitaxel, a drug to prevent restenosis, experienced lower rates of failure compared with patients treated with an uncoated balloon.
Researchers reported that patients treated with a balloon coated with paclitaxel, a drug to prevent restenosis, experienced lower rates of failure compared with patients treated with an uncoated balloon.
Researchers reported that...
03/11/2024
Cath Lab Digest
At-Risk Groups
More Than Half of American Indian Teens and Young Adults Have High Cholesterol
03/11/2024

American Heart Association News

American Heart Association News ...
Among American Indians 15 to 19 years old, 55% had high cholesterol. About 74% in their 20s had it, as did 78% of those in their 30s. By comparison, prior studies have shown about 25% of adolescents overall in the U.S. and about 30% of young...
Among American Indians 15 to 19 years old, 55% had high cholesterol. About 74% in their 20s had it, as did 78% of those in their 30s. By comparison, prior studies have shown about 25% of adolescents overall in the U.S. and about 30% of young...
Among American Indians 15 to 19...
03/11/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use